
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Raajit K. Rampal discloses the following relationships and financial interests:
-
AbbVie
Provision of Services -
CTI BioPharma Corp.
Provision of Services -
Chinese Medical Association
Provision of Services -
Cowen and Company, LLC
Provision of Services -
Galecto Biotech ApS
Provision of Services -
Greg Colman Law PC
Provision of Services -
Incyte
Provision of Services
-
Kartos Therapeutics, Inc.
Provision of Services -
MPN Research Foundation
Provision of Services -
MorphoSys AG
Provision of Services -
Novartis
Provision of Services -
Sierra Oncology, Inc
Provision of Services -
Stemline
Provision of Services -
Sumitomo Pharma
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures